6.165  0.145 (2.41%)		04-26 11:51
Open: 5.96 High: 6.165 Volume: 32,096		Pre. Close: 6.02 Low: 5.96 Market Cap: 15(M)

Short term
Mid term
Targets	6-month :	8.63	1-year :	9.71
Resists	First :	7.39	Second :	8.31
Pivot price	6.54
Supports	First :	5.9	Second :	4.9
MAs	MA(5) :	6.18	MA(20) :	6.8
	MA(100) :	7.76	MA(250) :	7.75
MACD	MACD :	-0.6	Signal :	-0.5
%K %D	K(14,3) :	13.2	D(3) :	16.1
RSI	RSI(14): 32.5
52-week	High :	9.97	Low :	4.57

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ PILL ] has closed above bottom band by 30.3%. Bollinger Bands are 30.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

If tomorrow:	Open lower	Open higher
High:	6.14 - 6.17	6.17 - 6.2
Low:	5.85 - 5.89	5.89 - 5.93
Close:	5.96 - 6.02	6.02 - 6.07

The fund invests at least 80% of its net assets in financial instruments, such as swap agreements, securities of the index, and ETFs that track the index and other financial instruments that provide daily leveraged exposure to the index or to ETFs that track the index. The index is a modified equal-weighted index that is designed to measure performance of the stocks comprising the S&P Total Market Index that are classified in the GICS pharmaceuticals sub-industry. The fund is non-diversified.

Wed, 17 Apr 2024
The 5 Best Healthcare ETFs of 2023 - etf.com

Wed, 06 Mar 2024
5 Biggest Biotechnology ETFs in 2024 - Investing News Network

Wed, 21 Feb 2024
Top Performing Leveraged/Inverse ETFs: 02/18/2024 - ETF Trends

Tue, 20 Feb 2024
5 Best Leveraged ETFs of First Half of Q1 - Yahoo Finance Australia

Fri, 12 Jan 2024
Top 25 Biotech Companies of 2024 - Genetic Engineering & Biotechnology News

Wed, 20 Dec 2023
AI Adoption in Healthcare Spells Opportunity in 2 ETFs - ETF Trends

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Neutral
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Neutral
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Neutral
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Neutral
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Neutral
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Neutral

Exchange: AMEX
Sector: Financial Services
Industry: Asset Management
Shares Out	0 (M)
Shares Float	0 (M)
Held by Insiders	0 (%)
Held by Institutions	0 (%)
Shares Short	0 (K)
Shares Short P.Month	0 (K)

EPS	0
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	0 %
Return on Assets (ttm)	0 %
Return on Equity (ttm)	0 %
Qtrly Rev. Growth	0 %
Gross Profit (p.s.)	0
Sales Per Share	0
EBITDA (p.s.)	0
Qtrly Earnings Growth	0 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	0 (M)

PE Ratio	0
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	0

Dividend	0
Forward Dividend	0
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.